Ashvattha Therapeutics, Inc.
Biotech/Healthcare - Redwood City, California, US
Ashvattha Therapeutics, Inc. Employees
Ashvattha Therapeutics, Inc. Senior Management
Ashvattha Therapeutics, Inc. Details
Ashvattha Therapeutics is developing a new class of drugs that identify and treat diseased cells with unprecedented precision. Our proprietary hydroxyl dendrimer (HD) platform, exclusively licensed from Johns Hopkins University, allows for the creation of hydroxyl dendrimer therapeutics (HDTs), which link known small molecule drugs to HDs for selective delivery with sustained effect in diseased tissues. We believe this approach to precision medicine has the potential to change the standard of care across neurology, ophthalmology, hyperinflammatory diseases and neuro-oncology.
Ashvattha Therapeutics, Inc. Technologies
Email Providers
Outlook
CMS
WordPress.org
Other
Mobile Friendly
Hosting
GoDaddy Hosting
Online Video Platforms
Vimeo